Legend Biotech (LEGN) Share-based Compensation Growth (1y) (2021 - 2026)
Legend Biotech (LEGN) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | 118.32% |
| 2 | Nanobiotix | 1,899.87 Bn | 1,899.81 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.43 Bn | 465.64 Bn | 1.35 Bn | -40.86% |
| 5 | Vertex Pharmaceuticals | 123.43 Bn | 116.19 Bn | 2.59 Bn | 0.18% |
| 6 | Regeneron Pharmaceuticals | 70.20 Bn | 61.44 Bn | 3.31 Bn | 5,886.05% |
| 7 | Belite Bio | 61.75 Bn | 61.75 Bn | - | - |
| 8 | Argenx Se | 56.15 Bn | 50.96 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn | - |
| 10 | Legend Biotech | 7.13 Bn | 6.48 Bn | 129.70 Mn | 21.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.38% |
| Sep 30, 2025 | -0.64% |
| Jun 30, 2025 | -13.78% |
| Mar 31, 2025 | -14.99% |
| Dec 31, 2024 | 6.35% |
| Sep 30, 2024 | 22.09% |
| Jun 30, 2024 | 38.95% |
| Mar 31, 2024 | 164.58% |
| Dec 31, 2023 | 40.30% |
| Sep 30, 2023 | 20.87% |
| Jun 30, 2023 | 65.54% |
| Mar 31, 2023 | 24.59% |
| Dec 31, 2022 | 72.56% |
| Sep 30, 2022 | 47.87% |
| Jun 30, 2022 | 65.52% |
| Mar 31, 2022 | 144.25% |
| Dec 31, 2021 | 69.71% |
| Sep 30, 2021 | 573.64% |